News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Lucy McCann: Would you choose private over NHS care?
Lucy McCann/LinkedIn
Jan 13, 2025, 16:13

Lucy McCann: Would you choose private over NHS care?

Lucy McCann, Medical Associate at ZOC, shared a recent article on LinkedIn:

“Would you choose private over NHS care?

Pleased to share our new publication exploring the recent trends in private orthopaedic care in England, which found considerable geographical inequalities.

Many thanks to my co-authors at the Health Equity Evidence Centre  – an excellent hub with evidence-informed solutions for equitable health and care.”

‘Analysis of orthopaedic private healthcare patterns in England: A potential emerging two-tier system‘

Authors: Lucy McCann, Ian Holdroyd, Rowan Emberson, Helena Painter and John Ford

Lucy McCann

For more updates, follow OncoDaily.

cancer England Health Equity Evidence Centre Ian Holdroyd Lucy McCann NHS care OncoDaily Oncology Rowan Emberson
Special Coverage
Oncolibrary
Jun 1, 2025, 18:59
SERENA-6 Trial at ASCO 2025: Camizestrant Plus CDK4/6i Improves Outcomes in HR+/HER2– Advanced Breast Cancer with ctDNA-Detected ESR1 Mutations
Stories
Jun 1, 2025, 17:19
Shrenik Shah’s Story from Cancer Survivor to Global Advocate: From Silence to Stages
Insight
Jun 1, 2025, 17:02
Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney
Blog
Jun 1, 2025, 16:55
Oriol Mirallas: Early Data on SYNC-T Therapy for mCRPC Presented at ASCO 2025
Blog
Jun 1, 2025, 16:52
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Insight
Jun 1, 2025, 16:46
Shanda Blackmon: First trial of CAR-T cell cancer treatment for solid tumor response
Oncolibrary
Jun 1, 2025, 16:39
MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment
Opinion
Jun 1, 2025, 16:37
Massimo Di Maio: Overall Survival Analysis Should NOT be Adjusted for Subsequent Treatments
Blog
Jun 1, 2025, 16:37
Paolo Tarantino Shares DB06 Biomarker Analysis Insights from ASCO 2025
Insight
Jun 1, 2025, 16:36
Rebecca Shatsky: It’s high time for an oral taxane in breast cancer
Blog
Jun 1, 2025, 16:26
Runcie C.W. Chidebe: Project PINK BLUE is Exhibiting at the ASCO25 Annual Meeting
Blog
Jun 1, 2025, 16:26
Oyepeju Abioye-Akintola: Thank you to the ecancer team for the wonderful interview at ASCO 2025